Suboptimal Nevirapine Steady-State Pharmacokinetics During Intrapartum Compared With Postpartum in HIV-1–Seropositive Ugandan Women
dc.contributor.author | Lamorde, Mohammed | |
dc.contributor.author | Byakika-Kibwika, Pauline | |
dc.contributor.author | Okaba-Kayom, Violet | |
dc.contributor.author | Flaherty, John P. | |
dc.contributor.author | Boffito, Marta | |
dc.contributor.author | Namakula, Rhoda | |
dc.contributor.author | Ryan, Mairin | |
dc.contributor.author | Nakabiito, Clemensia | |
dc.contributor.author | Back, David J. | |
dc.contributor.author | Khoo, Saye | |
dc.contributor.author | Merry, Concepta | |
dc.contributor.author | Scarsi, Kimberly K. | |
dc.date.accessioned | 2022-01-13T17:12:25Z | |
dc.date.available | 2022-01-13T17:12:25Z | |
dc.date.issued | 2010 | |
dc.description.abstract | Conflicting data exist regarding the effect of pregnancy on steady-state nevirapine pharmacokinetics (PK), although steady-state nevirapine concentrations during pregnancy have never been characterized in sub-Saharan Africa. Methods: This was a longitudinal intensive PK study in Ugandan pregnant women receiving nevirapine-based antiretroviral therapy. Participants underwent intensive 12-hour PK sampling during the second trimester (T2; n = 4), third trimester (T3; n = 15) and 6 weeks postpartum (PP; n = 15). HIV-1 RNAwas performed within 2weeks of each visit. Nevirapine C12 above 3000 ng/mLwas classified as optimal based on the suggested value for therapeutic drug monitoring. | en_US |
dc.identifier.citation | Lamorde, M., Byakika-Kibwika, P., Okaba-Kayom, V., Flaherty, J. P., Boffito, M., Namakula, R., ... & Scarsi, K. K. (2010). Suboptimal Nevirapine Steady-State Pharmacokinetics During Intrapartum Compared With Postpartum in HIV-1–Seropositive Ugandan Women. Journal of acquired immune deficiency syndromes (1999), 55(3), 345. | en_US |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594885/ | |
dc.identifier.uri | https://nru.uncst.go.ug/xmlui/handle/123456789/1269 | |
dc.language.iso | en | en_US |
dc.publisher | Journal of acquired immune deficiency syndromes | en_US |
dc.subject | Antiretroviral agents | en_US |
dc.subject | HIV | en_US |
dc.subject | Pregnancy | en_US |
dc.subject | Pharmacokinetics | en_US |
dc.subject | Sub-Saharan Africa | en_US |
dc.title | Suboptimal Nevirapine Steady-State Pharmacokinetics During Intrapartum Compared With Postpartum in HIV-1–Seropositive Ugandan Women | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Suboptimal Nevirapine Steady-State Pharmacokinetics.pdf
- Size:
- 178.97 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: